GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Il Yang Pharmaceutical Co Ltd (XKRX:007575.PFD) » Definitions » Other Income (Expense)

Il Yang Pharmaceutical Co (XKRX:007575.PFD) Other Income (Expense) : ₩-21,480.64 Mil (TTM As of Mar. 2025)


View and export this data going back to 1974. Start your Free Trial

What is Il Yang Pharmaceutical Co Other Income (Expense)?

Il Yang Pharmaceutical Co's other income expense for the Il Yang Pharmaceutical Co's pretax income for the three months ended in Mar. 2025 was ₩-24,475.26 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-21,480.64 Mil.

Il Yang Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for Il Yang Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Il Yang Pharmaceutical Co Other Income (Expense) Chart

Il Yang Pharmaceutical Co Annual Data
Trend Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,208.54 8,420.16 11,450.17 -15,314.51 3,589.06

Il Yang Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 923.20 -31.83 169.70 2,856.75 -24,475.26

Il Yang Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-21,480.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Il Yang Pharmaceutical Co  (XKRX:007575.PFD) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Il Yang Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Il Yang Pharmaceutical Co Ltd (XKRX:007575.PFD) » Definitions » Other Income (Expense)
Comparable Companies
XKRX:005500 XKRX:001630 XKRX:096760 XKRX:102460 XKRX:293480 XKRX:476060 XKRX:092040 XKRX:389470 XKRX:293780 XKRX:271980 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
007570:Korea
Address
110, hagal-ro, Giheung-gu, Yongin-si, Seoul, Gyeonggi, KOR
Website
http://www.ilyang.co.kr
Il Yang Pharmaceutical Co Ltd operates in the Korean healthcare sector. The company is mainly a pharmaceutical product manufacturer. Its business is comprised of four product divisions, which are Medicines, Food, Cosmetics, and Antacid raw materials. Its medicines include anticancer and antibiotics and drugs for the liver, digestive system, and anti-inflammatory drugs. Its Foods division is engaged in the manufacture and sale of food supplements and health drinks.

Il Yang Pharmaceutical Co Headlines

No Headlines